Author Login IJIRT Partner Network (IPN) Login

Hemolytic Disease of the Newborn (HDN)

  • Unique Paper ID: 161954
  • Volume: 10
  • Issue: 7
  • PageNo: 139-144
  • Abstract:
  • Hemolytic disease of the Newborn (HDN), also known as Erythroblastosis fetalis, is a hemolytic condition that generally affects rhesus-positive fetuses and babies born to rhesus-negative mothers. The pathophysiology of HDN begins with motherly antibodies attacking fetal red blood cells following alloimmunization due to rhesus or ABO incompatibility between the motherly and fetal blood. Preliminarily, HDN was known to cause death in 1 of all pregnancies, but with the arrival of immunoprophylactic therapies condition can be presently fairly well managed with smaller complications if diagnosed beforehand. To help the disease, before intravenous immunoglobulin (IVIG) should be given to pregnant Rh- women who haven't sensitized. The diagnosis and management of pregnant women with HDN is premised on laboratory and radiographic monitoring. This review covers the disorder’s etiology, pathophysiology, and administration, as well as treatment and their management to help in unborn investigation and confirmation-based medical practice.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 10
  • Issue: 7
  • PageNo: 139-144

Hemolytic Disease of the Newborn (HDN)

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry